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Modulation of Activated Leukocyte Cell Adhesion
Molecule–Mediated Invasion Triggers an Innate
Immune Gene Response in Melanoma
Jeroen W.J. van Kilsdonk1,7, Nozomi Takahashi2, Ulrich Weidle3, Helmut Burtscher3, Jonathan Jarry4,
Mohamed R. Daha5, Guido W.M. Swart1 and Le´on C.L.T. van Kempen4,6
Activated leukocyte cell adhesion molecule (ALCAM/CD166) is a progression marker of a variety of cancers,
including melanoma, and is a marker for mesenchymal stem cells. ALCAM expression triggers matrix
metalloproteinase activity and correlates with the transition between superficial melanoma growth and deep
dermal invasion in vivo. We previously showed that manipulating ALCAM functionality could both decrease and
increase melanoma invasion, depending on the manner by which ALCAM function was altered. How ALCAM
exerts these opposing invasive phenotypes remained elusive. In the present study, we analyzed differences in
melanoma cell gene expression in two- and three-dimensional cultures as function of ALCAM-mediated
adhesion. We identified a cluster of genes highly responsive to ALCAM functionality and relevant for melanoma
invasion. This cluster is characterized by known invasion-related genes similar to L1 neuronal cell adhesion
molecule and showed a remarkable induction of several innate immune genes. Unexpectedly, we identified
major variations in the expression of genes related to an immunological response when modulating ALCAM
function, including complement factors C1r and C1s. The expression and function of these proteinases were
confirmed in protein assays and in vivo. Together, our results demonstrate a link between ALCAM functionality
and the immune transcriptome, and support the assumption that ALCAM–ALCAM interactions could function as
a cell signaling complex to promote melanoma tumor invasion.
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INTRODUCTION
Cell adhesion molecules have an important role during most
stages of tumor progression. Tumors use adhesion molecules
to form a solid mass, whereas metastasizing tumor cells
continuously alter the repertoire of adhesion molecules
during invasion, detachment from the primary tumor mass,
intra- and extravasation, and outgrowth at secondary sites.
We have previously demonstrated that progression of
cutaneous melanoma is characterized by de novo expression
of activated leukocyte cell adhesion molecule (ALCAM/
CD166) at the invasive front of the tumor (van Kempen et al.,
2000). ALCAM expression correlates with the transition from
local cell proliferation to invasive tumor growth and suggest
that it has an important role in melanoma invasion and
metastasis.
ALCAM is a homophilic and heterophilic (ALCAM-CD6)
adhesion molecule belonging to the Ig superfamily (Bowen
et al., 1995; Degen et al., 1998). Both the heterophilic and
homophilic ALCAM interactions are mediated by the N-
terminal part of ALCAM (trans-interactions), whereas lateral
oligomerization of ALCAM molecules on the cell surface (cis-
oligomerization) is mediated by three membrane proximal
C-type domains (Bowen et al., 2000; van Kempen et al.,
2001). Together cis-oligomerization on the cell surface and
trans-intercellular interactions would synergistically promote
ALCAM recruitment and network formation at sites of
cell–cell contact (Swart et al., 2005).
The molecular and cellular effects of ALCAM-mediated
adhesion on invasion and metastasis remain largely elusive.
Migration in cell clusters has several advantages over
disseminating individual cells and is a potentially important
mechanism of metastasis: protection of inner cells from
immunological assault, and higher production of pro-
migratory factors and matrix proteases (Friedl et al., 2004).
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To understand the effects of ALCAM function on melanoma
cells, we have engineered various melanoma cell lines that
express different ALCAM variants (van Kempen et al., 2004b;
van Kilsdonk et al., 2008). Indeed, we could demonstrate that
ALCAM–ALCAM clustering critically contributes to activation
of the pro-invasive matrix metalloproteinase (MMP)14 and
MMP2 (Lunter et al., 2005; van Kilsdonk et al., 2008). In
addition, ALCAM-mediated adhesion increases the expres-
sion of L1 neuronal cell adhesion molecule (L1CAM/CD171),
a melanoma progression marker that is similar to ALCAM,
which is associated with increased metastatic potential (van
Kilsdonk et al., 2008). Impairing ALCAM-mediated adhesion
by ectopic expression of N-terminally cleaved ALCAM (DN-
ALCAM) reduced melanoma cell aggregation, and increased
their single-cell mobility and invasiveness in skin recon-
structs. In addition, an acceleration of spontaneous lung
metastasis formation was observed at expense of primary
tumor growth in mouse xenografts (van Kempen et al.,
2004b). Unexpectedly, a small secreted form of ALCAM
(sALCAM) that is anticipated to prevent ligand binding (Ikeda
and Quertermous, 2004), did attenuate the formation of an
intercellular ALCAM network but did not accelerate mela-
noma invasion in vitro and lung metastasis in nude mice (van
Kilsdonk et al., 2008). However, sALCAM-induced inhibition
of invasion and metastases correlated with loss of L1CAM
expression and MMP2 activity. Therefore, DN-ALCAM and
sALCAM both interfere with ALCAM function albeit in yet
unknown different manners. Although they have an opposing
effect on invasion, disturbing ALCAM function coincides with
differential expression and activity of invasion-related
L1CAM and MMP14/MMP2 (van Kempen et al., 2004b; van
Kilsdonk et al., 2008). As such, we have obtained cell lines
derived from one parental line, i.e., BLM, that differ in
invasive and metastatic properties solely due to altered
ALCAM function.
In the present study, we have cultured these melanoma
cells in two-(2D) and three-dimensional (3D) conditions and
performed array-based gene expression analyses. Coupling of
the expression profiles to their cellular phenotype resulted
in the identification of gene clusters that are associated with
ALCAM-mediated cell adhesion and the invasive and
metastatic potential. A selection thereof was validated by
quantitative PCR. Unexpectedly, a large proportion of genes
associated with invasion are involved in immunological
processes, including classical complement proteases C1r and
C1s. Expression and activity of these proteases was confirmed
on protein level and demonstrated an ALCAM function
dependency. To our knowledge these aspects of ALCAM in
melanoma biology are previously unreported. Its adhesive
function contributes to invasion by strongly modulating the
expression of immune response genes. To our knowledge,
this is previously unreported.
RESULTS
Genes responsive to ALCAM status and cell clustering identified
by complementary DNA (cDNA) microarray analysis
Differential expression of ALCAM function-dependent genes
could be involved in the previously reported phenotypic
transition from localized primary melanoma growth to
strongly increased invasion and metastasis by ectopic DN-
ALCAM expression (van Kempen et al., 2004a) or, con-
versely, ablation of the invasive phenotype by sALCAM
expression (van Kilsdonk et al., 2008). A gene-expression
microarray experiment was performed to reveal a relation-
ship between ALCAM functionality, differential gene expres-
sion profiles, and invasive properties of melanoma cells. We
compared the transcript levels of metastatic BLM cells,
extremely metastatic BLM/DN-ALCAM cells (van Kempen
et al., 2004b) and poorly metastatic BLM/sALCAM cells (van
Kilsdonk et al., 2008).
In order to illustrate the effect of increasing cell
confluence, and thus intercellular ALCAM clustering, on
gene expression, we compared the transcript levels of cells
harvested under sub-confluent and super-confluent culture
conditions. Under sub-confluent conditions the degree of
cell–cell and intercellular ALCAM–ALCAM contact forma-
tions was limited, whereas multiple cell–cell contacts were
present when melanoma cells piled up in super-confluent
cultures.
While selecting for more than 2-fold expression changes, a
set of 773 genes was identified in high-density cultures of
parental BLM cells compared with a low-density BLM culture
(Figure 1a). Within this set, only 97 genes were down-
regulated. Density-induced differential gene expression of a
selection of genes was validated using quantitative real-time
reverse transcription-PCR (qPCR; not shown). Differential
gene expression in response to cell density was also observed
in BLM/DN-ALCAM and BLM/sALCAM cells. Increased
density of BLM/DN-ALCAM cells resulted in the differential
regulation of 560 genes, of which 104 genes were down-
regulated (Figure 1a). Expression of 257 genes was found
to be differentially regulated in the non-metastatic BLM/
sALCAM cells at different cell densities, again a relatively
small number of genes (n¼75) was downregulated
(Figure 1a). From this we conclude that increased cell density
mainly induces gene expression and that this cell density
response is tempered in the BLM/sALCAM cells.
Genes that are upregulated in invasive BLM and BLM/DN-
ALCAM cells, but not in the poorly invasive BLM/sALCAM
cells, might explain the different invasive phenotypes.
Therefore, coupling these BLM phenotypes to their transcrip-
tome might reveal genes important for invasive growth. A set
of 385 genes (cluster Dþ cluster G, Figure 1a) was
differentially expressed by the two invasive cell lines upon
increased cell density. Of these, expression of 147 genes
(cluster G) was also found in non-invasive BLM/sALCAM
cells and indicates that their increased expression in response
to cell density was not affected by ALCAM integrity.
Therefore, the 238 genes in cluster D (Figure 1a) could
contribute to the invasive phenotype of BLM and BLM/DN-
ALCAM cells.
An immunological response signature is associated with
invasion
We analyzed the functional classes of differentially expressed
genes in cluster D in more detail to understand the molecular
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signature underlying the invasive capacity of these cells.
Figure 1b summarizes the gene ontology (GO) and pathways
that were found to be significantly enriched in invasive
melanoma cells at high cell density compared with non-
metastatic BLM-sALCAM cells. Strikingly, an immunological
response signature was most abundant in cluster D. Comple-
ment activation genes seem to characterize this response.
Besides this major response, known melanoma progression-
related responses like angiogenesis and cell adhesion were
observed.
We next cultured the three cell lines in 3D collagen gels to
mimic a more in vivo-like situation. Of the 238 genes
associated with metastasis in 2D cultures (cluster D, Figure
1a), 83 genes were also highly expressed by the metastatic
cells in 3D collagen. Furthermore, GO analysis of these 83
genes (Figure 1c), resulted an almost identical histogram with
the group of genes involved in the immunological response as
a dominant feature.
Confirmation of altered L1CAM expression at protein level
To verify if our approach revealed a gene response that could
contribute to tumor progression, we examined the protein
expression of a known tumor progression marker picked up
by our microarray analysis and present in cluster D. As a
marker present in many tumor types, including melanoma,
L1CAM/CD171 was selected (Thies et al., 2002; Talantov
et al., 2005; Meier et al., 2006). Western blot analysis
(Figure 2a) demonstrated the highest expression of L1CAM in
BLM/DN-ALCAM cells, limited expression in parental BLM
cells, and no expression in BLM/sALCAM cells. Increased cell
density and thus increased ALCAM-mediated cell adhesion
induced upregulation of L1CAM expression in BLM and BLM/
DN-ALCAM cells but not in BLM/sALCAM cells. The protein
data are in line with the mRNA expression levels found in the
microarray analysis and shows that L1CAM expression is
highly upregulated by cell clustering. These data confirm our
previous observation that ALCAM functionality regulates
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Figure 1. Microarray results overview, effects of activated leukocyte cell adhesion molecule (ALCAM) status, and cell density. (a) Venn diagram of gene
expression levels comparing monolayer cultures of BLM, BLM/sALCAM, and BLM/DN-ALCAM cells grown at low and high cell density. For each
cell line, all genes with a significant (Po0.05) differential expression (42 ) upon cell clustering are depicted. Numbers between brackets represent the
number of genes that are downregulated per cluster. (b) Number of genes belonging to a significant gene ontology term or a significant pathway that
were either upregulated or downregulated and belong to the invasive cluster D from panel a. (c) Three-dimensional collagen cultures of BLM,
BLM/sALCAM, and BLM/DN-ALCAM cells grown at high cell density are compared using microarray analysis. Growth of these cells in collagen
reveals that the gene response for 83 out of the 238 genes found in cluster D was maintained when these cells were cultured as high cell density
collagen gels. Gene ontology of these genes is given. MHC, major histocompatibility complex.
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L1CAM protein expression (van Kilsdonk et al., 2008) and
demonstrates that L1CAM expression is increased with
increasing cell density.
Confirmation of altered C1r and C1s expression at protein levels
The major response upon cell clustering and related to
invasion appears to be of immunological origin enriched for
complement genes (Figure 1). Many of these genes were
previously not linked to melanoma progression or to tumor
progression in general. These genes might be interesting new
candidates that could have a role in melanoma tumor
progression.
Differential expression of the classical complement
cascade proteases C1r and C1s mRNAs was confirmed on
protein level by western blot analyses. Figure 2b shows that
secretion of both C1r and C1s is hardly detected in medium
from BLM, BLM/DN-ALCAM, and not in medium BLM/
sALCAM cells grown at low cell density. However, increasing
the cell density significantly enhanced the expression of C1s
in all three cell lines. Expression was highest in BLM/DN-
ALCAM cells and lowest in BLM/sALCAM cells, and reflects
the mRNA expression profile. Similar responses to ALCAM
functionality and cell density changes were observed for C1r
expression (Figure 2b), although the expression levels were
low compared with C1s.
To demonstrate that the tumor cell lines produced
proteolytic active C1s and C1r, C4 hemolytic activity was
determined as described previously (Doekes et al., 1983).
Increasing cell density increased the C4 consumption by all
cell lines, however, C4 consumption was less in the medium
of sALCAM-expressing cells (not shown). This is consistent
with the lower amount of C1r and C1s proteins present in the
BLM/sALCAM-conditioned medium (Figure 2b). These pro-
tein data not only confirmed high expression of C1s and C1r
in response to increased cell density and ALCAM status, but
also demonstrate that they are proteolytically active.
Although we found C1r and C1s expression on mRNA
level in nevi, there is no correlation with ALCAM expression,
we did find a significant positive correlation between
expression of ALCAM and C1r, ALCAM and C1s, and C1r
and C1s on mRNA level in 10 thick (41.5mm) melanoma
samples (Pearson correlation X0.859 and Pp0.001 for all
comparisons, Figure 3). To confirm protein expression and
protein localization in human melanomas, an immunohisto-
chemical staining was performed on formalin-fixed and
paraffin-embedded tissues. In all, 7 of the 10 melanomas
analyzed did display C1s expression. At present, a good
antibody for immunohistochemistry toward C1r is not
available. Representative images of C1s-positive melanomas
are shown in Figure 4 and revealed a gradual increase in
cytoplasmic C1s staining intensity (Figure 4a–d), with highest
intensities in the most invasive component (Figure 4d).
Moderate (Figure 4f) and low (Figure 4h) cytoplasmic C1s
expression could be observed. This small sample set
confirmed that C1s can be expressed by primary cutaneous
melanomas at the protein level, and that its expression
increased with increasing thickness.
C1r and C1s density effects in different tumors
The increased expression levels of C1r and C1s in BLM cells
upon cell clustering could be cell line–specific artifact. To
show that the response to increased density is more universal,
we determined the mRNA expression levels of C1r and C1s
in another melanoma cell line and several different tumor
cell lines using qPCR. In Figure 5, black bars represent C1r
and C1s expression levels at low cell density, whereas white
bars represent expression levels at high cell density. In the
HT1080 fibrosarcoma cell line, a massive increase in
expression of both proteins is observed when cell density is
increased. Actually, in all cell lines tested the increase in
expression is observed although at different levels. Except for
the expression of C1r in CaCO2 cells, which does not
increase upon cell density changes. This increased expression
also correlates to ALCAM expression in these cell lines
(Degen et al., 1998). These data show that the cell clustering
gene response is a more general phenomenon and that,
besides in melanoma, C1r and C1s might have a role in
several other solid ALCAM-positive tumors.
DISCUSSION
A remarkable increase of the metastatic capacity of ALCAM-
expressing melanoma cells can be observed by ectopic
expression of DN/ALCAM, whereas overexpression of sAL-
CAM decreases invasion and metastasis rate. In the present
study, we have identified the gene expression signature that is
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Figure 2. Expression of L1 neuronal cell adhesion molecule (L1CAM), C1r,
and C1s in melanoma cells, effects of activated leukocyte cell adhesion
molecule (ALCAM) status, and cell density. (a) Western blot analysis of cell
lysates of BLM, BLM/sALCAM, and BLM/DN-ALCAM cells cultured as
monolayers at high and low density. BLM and BLM/DN-ALCAM (DN) cells are
positive for L1CAM with an increase in L1CAM expression when the cell
density increases. In contrast, BLM/sALCAM (sA) have no L1CAM expression
regardless of cell density. Both full-length and plasmin-cleaved L1 are
detected. b-Actin serves as a loading control. (b) Western blot analysis was
performed after precipitation of conditioned media. BLM, BLM/sALCAM, and
BLM/DN-ALCAM cells were cultured as monolayers at low (L) and high (H)
cell density. All cell lines are negative for C1r and C1s expression at low cell
density. With increasing cell density expression of C1r and C1s is dramatically
increased in BLM and BLM/DN-ALCAM cells. Expression of C1r and C1s in
BLM/sALCAM cells hardly respond to cell density changes.
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associated with the invasive phenotype modulated by cell
density and ALCAM functionality. The preponderance of
genes that were regulated by increased cell density and
related to invasion involves innate immune responses and
known invasion-related genes like L1CAM. The ALCAM
functionality and invasion-related innate immune response is
characterized by increased expression of biologically active
complement proteases C1r and C1s in cell lines. The
observation that C1s is indeed expressed in human melano-
mas and that C1r and C1s are increasingly expressed by other
ALCAM-expressing cell lines as a result of increased cell
density indicate that the cell clustering effects may be more
generally applicable to a broader spectrum of ALCAM-
positive tumor cells. The ALCAM effects observed here are
well compatible with a networking role of ALCAM that
integrates complex, microenvironmental signaling determin-
ing invasion.
The present set of experiments identifies a set of genes
induced by increased melanoma cell clustering and asso-
ciated with invasion. We compared their expression in the
invasive BLM cell lines with a previous published invasive
melanoma 54-gene signature based on a large panel of
melanoma cell lines (Hoek et al., 2008). The genes present in
the BLM invasion signature are highly consistent with Hoek’s
invasive gene expression signature. We calculated that the
likelihood that this overlap occurs by chance is Po1014.
Among these overlapping genes (n¼17) are important
regulatory genes like WNT-5A, CXCL-2, and IL-8. Hoek
et al. also describe a proliferative gene signature associated
with low motility and high proliferation. Although modula-
tion of ALCAM function with sALCAM ablates the invasive
and metastatic properties, and loss of invasion-related gene
expression, these cells did not display a proliferative gene
expression signature. These data suggest that ALCAM
primarily fine-tunes the invasive properties of melanoma
cells, but that ALCAM–ALCAM adhesion does not affect
proliferation. The role of ALCAM in invasion is further
emphasized when comparing our data with the gene
expression profiles coming from primary metastatic melano-
mas (Winnepenninckx et al., 2006). From the genes
associated with distant metastasis-free survival, not a single
gene was found in our data set, most likely excluding a role
for ALCAM in later stages of melanoma progression. All these
expression data indicate that ALCAM functions as a signaling
molecule that can affect the invasive behavior of melanoma
cells, which is in line with the expression pattern of ALCAM
at the invasive front of primary melanomas (van Kempen
et al., 2000).
Sustained tumor cell proliferation within the expanding
tumor mass may increase homotypic cell–cell clustering,
which favors signaling responses promoting invasive growth
and migration. The comparison of low-confluent cultures to
super-confluent cultures used here may partly mimic some of
the physiological signals induced by the rapid expansion of
tumor tissue. High cell density has been shown to alter
several cellular processes and may drive acquisition of
mesenchymal traits by prostate cancer cells (Ke et al.,
2011). In addition, high cell density selectively enhances
0.50
0.40
0.30
0.20
R
el
at
iv
e 
C1
s 
ex
pr
es
sio
n
R
el
at
iv
e 
C1
r e
xp
re
ss
io
n
0.10
0.00
5.00
4.00
3.00
2.00
R
el
at
iv
e 
C1
r e
xp
re
ss
io
n
1.00
0.00
5.00
4.00
3.00
2.00
1.00
0.00
0.00
Pearson correlation: 0.975
P < 0.001
Pearson correlation: 0.905
P < 0.001
Pearson correlation: 0.859
P = 0.001
0.10 0.20 0.30
Relative ALCAM expression
0.40 0.50 0.60
0.00 0.10 0.20 0.30
Relative C1s expression
0.40 0.50
0.00 0.10 0.20 0.30
Relative ALCAM expression
0.40 0.50 0.60
Figure 3. C1r, C1r, and activated leukocyte cell adhesion molecule (ALCAM) expression levels in primary melanoma. Scatter plots of C1s and ALCAM
expression (a), C1r and ALCAM expression (b), and C1r and C1s expression (c) levels in 10 primary cutaneous melanomas. A significant positive correlation was
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expression. Each sample was analyzed in triplicate and mean values plotted.
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avb6 integrin expression in a protein kinase C–dependent
manner in colon cancer lines (Niu et al., 2001). Previously
we demonstrated that ALCAM status controls MMP-
14–mediated activation of pro-invasive proteinase MMP-2
in collagen matrices (Lunter et al., 2005; van Kilsdonk et al.,
2008). In this report, we demonstrate that ALCAM function
also modulates the expression of the melanoma progression
marker L1CAM (Thies et al., 2002; Primiano et al., 2003;
Talantov et al., 2005; Meier et al., 2006) and that its
expression correlates with the invasive phenotypes of the
BLM/ALCAM cell lines. The exact molecular mechanism that
can explain the different effects of DN-ALCAM and sALCAM
on L1CAM expression is subject of our further studies.
Expression array and immunohistochemical data pointed
toward a role for ALCAM in modulating the expression genes
related to an immune response. Expression of complement
proteases C1r and C1s in the variant BLM cell lines is
comparable to that of L1CAM. The overall expression profile
suggests that MMP-2 activation, L1CAM, C1r, and C1s are
linked to ALCAM status and directly correlate with invasive
c
d
f
h
*
*
*
*
Figure 4. C1s expression in primary melanoma. C1s expression varies within and between melanomas and comprises (i) gradual increase within a
melanoma (a–d) where a more intense expression is observed in the most invasive component (c versus d), (ii) moderate expression (e,f), and (iii) low
expression (g,h). Bars¼960 mm (a,b), 240mm (e,g), 60 mm (c,d), 30mm (f,h). a,e,g: Hematoxylin and eosin. Asterisks in f indicate melanophages.
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potential. Complement components have been marginally
linked to human cancers, although at present it is difficult to
predict whether these proteins promote or inhibit the growth
and development of malignant tissues (Markiewski and
Lambris, 2009). To our knowledge, the expression of
complement components C1r and C1s in relation to
melanoma or tumor progression in general has never been
examined. The strong upregulation in correlation with
ALCAM expression in several tumor cell lines of different
pathological origin (Degen et al., 1998) hints to a more
general contribution of C1r and C1s in tumor progression.
Next to C1r and C1s, most of the genes responsive to
ALCAM functionality such as chemokines, chemokine
receptors, and complement component 3 belong to the
innate immune response (Figure 1b and c). From this it is
tempting to speculate about a more general role of ALCAM in
the regulation of a tumor-related innate immune responses.
This pro-tumor inflammation response might work in synergy
with activated tumor stroma cells like tumor-associated
macrophages in order to increase immune-regulated pro-
cesses like angiogenesis. (DeNardo et al., 2008; Solinas et al.,
2010). To confirm the possible correlations between ALCAM,
innate immunity, and C1r/s expression in melanoma and how
this contributes to melanoma invasion requires further studies.
The contribution of ALCAM to the different responses
upon sALCAM and DN/ALCAM overexpression may be
explained by its trans and cis interactions (van Kempen
et al., 2001). Downstream effects of ALCAM functionality
seem to be generated in two ways; first, receptor–ligand
interactions of ALCAM between two opposing cells (trans-
clustering) and second, multimerization of ALCAM on the
surface of one cell (cis-clustering). The divergent effects in the
C1r/s and L1CAM profile between sALCAM and DN/ALCAM
expression suggest an inverse relation between the extent of
ALCAM cis-clustering and transcription levels of these target
genes. Full reduction on protein level can only be achieved
after sALCAM expression, whereas the expression of DN-
ALCAM may generate additional crosstalk to increase the
response amplitude. This interpretation is consistent with
aberrant, constitutively elevated cis-clustering upon over-
expression of DN-ALCAM and the absence of cis-clustering in
sALCAM cells (van Kilsdonk et al., 2008). In contrast,
functional regulation of MMP-2 activation requires increasing
trans-clustering of ALCAM at the cell surface, which are
absent in both sALCAM- and DN-ALCAM-expressing cells
(Lunter et al., 2005; van Kilsdonk et al., 2008). The
identification of the dual response profiles is in agreement
with a complex sensor role in progressive cell confluence,
which registers the extent of cell clustering (i.e., cell density)
and controls the subsequent responses.
ALCAM may have a prominent sensor role in melanoma
tumor development, but an exclusive contribution cannot be
claimed in tuning of growth and cell confluence. The
existence of additional, parallel control factors is supported
by the detection of an ALCAM-independent, cell-confluence-
responsive set of genes (Figure 1, 147 genes) in our
microarray analyses. Therefore, it is tempting to speculate
that more cell–cell adhesion molecules, alone or in coopera-
tive assemblies, may fulfill similar sensor roles in different
cellular contexts. ALCAM cis-clustering might be a key event
in the generation of these assemblies. The apparent connec-
tion between ALCAM and cell confluence defines a new
prototype of growth response, which still needs to be linked
to the grossly characterized cell signaling networks. We have
provided experimental support that ALCAM-mediated adhe-
sion causes transcriptional and post-translational effects on
melanoma progression markers and have identified that this
also triggers the expression of immune response-related
genes. These observations support the assumption that
ALCAM and cell clustering coordinate the process of invasive
melanoma growth.
MATERIALS AND METHODS
Cell culture
Adherent melanoma (BLM, WM164), fibrosarcoma (HT1080), colon
carcinoma (CaCo-2), and prostate carcinoma (PC3) cells were
maintained as monolayers in DMEM (Invitrogen, Bleiswijk, the
Netherlands) containing 10% fetal calf serum, 4mM L-glutamine, and
2mM pyruvate. BLM/DN-ALCAM and BLM-sALCAM were cultured
as described previously (Degen et al., 1998; van Kempen et al.,
2001; van Kilsdonk et al., 2008). Monolayer cell cultures were
grown at low and high cell confluence (o1 105 and
42.5 105 cells per cm2, respectively). Three-dimensional collagen
cultures containing 1 106 cells are prepared as described
previously (Lunter et al., 2005).
cDNA preparation and GeneChip array hybridization
RNA was isolated from 2D cultures in triplicate, and from 3D gels in
triplicate (six gels per sample) using the RNeasy kit (Qiagen, Venlo,
the Netherlands). Total RNA (1mg) was used as starting material for
cDNA preparation. One-cycle amplification protocol was followed.
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Figure 5. Expression of C1r and C1s in a panel of tumor cell lines.
Quantitative PCR analysis of C1r and C1s mRNA levels in HT1080, PC3,
Wm164, and CaCo-2 cells. Cells were cultured as monolayers at low (L) and
high (H) cell density. Messenger RNA levels of cells cultured at low density
(black bars) were compared with messenger levels of cells at high density
(white bars). For each gene and each cell line expression levels at low density
were set as 100%. Increased culture density significantly increased the
expression of C1r and C1s in all cell lines, except C1r expression in CaCo-2
cells is unaffected by density changes.
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Generation of biotinylated cRNA and subsequent hybridization to
U133Plus 2.0 oligonucleotide arrays (Affymetrix, Santa Clara, CA),
washing, and staining were performed according to Affymetrix
Expression Analysis Technical Manual for two-cycle amplification
(Lockhart et al., 1996). The arrays were then scanned using a laser
scanner GeneChip Scanner (Affymetrix) and analyzed by using
Affymetrix GeneChip Operating Software (GCOS version 1.4)
according to the manufacturer’s instruction.
High-level analysis of oligonucleotide array
Array normalization, expression value calculation, clustering, and
principal component analysis were performed using DNA-Chip Analyzer
(dChip) version 1.3 (Li and Wong, 2001). The Invariant Set Normali-
zation method and the model-based method were used for computing
expression values (Li andWong, 2001). These values were expressed as
mean and standard errors. Criteria of42-fold and Po0.05 were applied
for comparison. Functional cluster analysis was performed by dChip,
incorporating GO terms as well as pathways collection from GenMAPP
and Kyoto Encyclopedia of Genes and Genomes (Zhong et al., 2003).
For functional clusters, Po0.001 was considered statistically sig-
nificant. Genome information was obtained from NetAffx (http://
Affymetrix.com) and was based on UCSC Genome Bioinformatics.
Statistics
Statistical analysis for array-based gene expression was performed
using dChip. The t-statistic was computed as (mean1 – mean2)/ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SEðmean1Þ2 þ SEðmean2Þ2
q
, and its P-value is computed based on
the t-distribution, and the degree of freedom is set according to
Welch modified two-sample t-test (Li and Wong, 2001). The
statistical significance of GO term, protein domain, and pathway
frequency was calculated as probability of observing at least k probe
sets annotated with a particular classification within a list of selected
probe sets (cluster) of size n
P ¼ 1
Xk1
i¼0
f
i
 
g  f
n  1
 
g
n
 
where f was the total number of genes within a functional category,
and g was the total number of probe sets on the chip set (Tavazoie
et al., 1999). Sample classification was performed by dChip based
on linear discriminating analysis and Principal component analysis
(Raychaudhuri et al., 2000). Correlation coefficient analysis was
performed based on Pearson’s linear regression model. Po0.05 was
considered statistically significant.
Western blotting
Cell extracts and western blots were prepared as described
previously (van Kilsdonk et al., 2008). Serum-free media were
precipitated using 2-propanon at 70 1C for 20minutes followed by
90minutes at 20 1C; precipitates dissolved in reducing sample
buffer, separated by SDS-PAGE and transferred to polyvinylidene
difluoride membrane (Millipore, Amsterdam, the Netherlands). mAb
L1-11A was used for the detection of L1CAM (kindly provided by
Dr Altevogt) and rabbit-anti-C1R antibody (kindly provided by
Dr Arlaud). If indicated blots were stripped and re-probed for b-actin
(Sigma-Aldrich, Zwijndrecht, the Netherlands).
qPCR analysis of ALCAM, C1s, and C1r expression levels
in tissue
Tumor cells were macro-dissected from 10 different formalin-fixed,
paraffin-embedded tumor specimens (5 nodular and 5 superficial
spreading melanomas with a tumor thickness of more than 1.5mm),
and 10 congenital nevi. Total RNA was isolated with the RecoverAll
Total Nucleic Acid Isolation Kit for formalin-fixed, paraffin-
embedded Tissue (Ambion, Amsterdam, the Netherlands) according
to the manufacturer’s protocol. cDNA was generated from 300ng
total RNA with the iScript cDNA Synthesis kit (Bio-Rad, Veenendaal,
the Netherlands) using random primers in a total volume of 20 ml.
SYBR Green-based quantitative PCR (ABI 7500 Fast, Applied
Biosystems, Amsterdam, the Netherlands) was performed using
GoTaq qPCR Master Mix (Promega, Leiden, the Netherlands), 10
times diluted cDNA, and 350ng forward and reverse primers for
ALCAM (50-CCTTGTTGCTGGTGTCGTCTACT-30 and 50-ATTACC-
GAGGTCCTTGTTTACATGT-30), complement C1r (50-CTGCTGACC
TTCCACACAGA-30 and 50-TCAAGGTCCACAGCTTGGTAG),
complement C1s (50-GAAGTTGTGGAGGGACGTGT-30 and 50-AATG-
CCACAGTCCACAGGTT-30), or glyceraldehyde-3-phosphate dehy-
drogenase (50-TGGAAGGACTCATGACCACA-30 and 50-GAGG-
CAGGGATGATGTTCTG-30). Samples were analyzed in triplicate.
All primer pairs display an efficacy of amplification between 90 and
110%. qPCR analysis on tumor cell lines were performed as described
previously (Lunter et al., 2005).
Human tissues
Formaldehyde-fixed and paraffin-embedded primary cutaneous
melanomas (n¼ 10) with known follow-up were obtained from
the pathology archives of the Radboud University Nijmegen
Medical Centre For qPCR analyses, thick (41.5mm) primary
melanomas (n¼ 10) and congenital nevi (n¼ 10) from adult
patients (n¼ 10) were retrieved. Tissues were obtained according
to local ethical guidelines and approved by the local regulatory
committee. Dutch laws consider human tissue left over from
surgery as material that can be used for scientific research, and
which does not require patient consent when tissue is fully
anonymized.
Immunohistochemistry
Paraffin-embedded (4 mm) tissue sections were de-waxed and
rehydrated through graded alcohols. Following antigen retrieval
with pronase (0.1% in phosphate-buffered saline, 15minutes at
37 1C), tissues were preincubated with 20% normal horse serum
for 20minutes and subsequently incubated with a mAb toward
C1s (clone M81, 50 mgml1, Hycult Biotechnologies, Uden, The
Netherlands) overnight at 4 1C (Matsumoto and Nagaki, 1986).
Liver tissue was used as a positive antibody control, a non-
relevant IgG was taken along as a negative control. Binding
was visualized using Fast Red as a chromogen via the standard
ABC-method (Vector Laboratories, Amsterdam, the Netherlands).
Tissues were briefly counterstained with hematoxylin and
mounted with Imsol mounting medium (Klinipath BV, Duiven,
The Netherlands).
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